Skip to main content
. 2015 Jul 15;8(7):10515–10536.

Figure 5.

Figure 5

Forrest plots and meta-analysis of HR of high expression level of intratumoral and peripheral IL-17 compared to low in patients with solid tumors. The combined HRs of intratumoral IL-17 on (A) clinical staging, (B) overall survival (OS) and (C) disease free survival (DFS) were respectively aggregated above. The HR of peripheral IL-17 on (D) OS of patients with solid tumors was also evaluated.